Immunoscintigraphy
Immunoscintigraphy is a nuclear medicine procedure used to find cancer cells in the body by injecting a radioactively labeled antibody, which binds predominantly to cancer cells and then scanning for concentrations of radioactive emissions.[1][2]
| Immunoscintigraphy | |
|---|---|
| Purpose | detect cancer cells |
Clinical applications
Immunoscintigraphy is performed using a variety of radiopharmaceuticals, for a large range of purposes. Colorectal cancer is one of the most studied areas, with indium-111 or technetium-99m labelled epitopes of the carcinoembryonic antigen.[3] The antibody capromab pendetide reacts with prostate membrane specific antigen (PMSA) and can be labelled with 111In.[4]
gollark: Wow, the .xyz registrar or something is awful.
gollark: I see.
gollark: But it's quite long and I run some non-web services.
gollark: While tempting, the renewal prices will be so æ.
gollark: This is slightly outside my budget.
See also
References
- "Imaging Techniques for the Diagnosis of Ovarian Cancers: Immunoscintigraphy". 21 December 2004.
- "Immunoscintigraphy". NCI Dictionary of Cancer Terms. National Cancer Institute. Retrieved 1 June 2017.
- Matzku, Siegfried; Stahel, Rolf A (1999). Antibodies in Diagnosis and Therapy. CRC Press. p. 143. ISBN 9789057023101.
- Fass, Leonard (August 2008). "Imaging and cancer: A review". Molecular Oncology. 2 (2): 115–152. doi:10.1016/j.molonc.2008.04.001. PMC 5527766. PMID 19383333.
| X-ray/ Radiography |
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRI | |||||||||||||
| Ultrasound | |||||||||||||
| Radionuclide |
| ||||||||||||
| Optical/Laser | |||||||||||||
| Thermography |
| ||||||||||||
| Target conditions |
| ||||||||||||
| |||||||||||||
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.